Get the Stockscreener App
101.76
0.91%
-0.93
After Hours:
101.37
-0.39
-0.38%
Boston Scientific Corp stock is traded at $101.76, with a volume of 6.76M.
It is down -0.91% in the last 24 hours and up +2.54% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
See More
Previous Close:
$102.69
Open:
$102.27
24h Volume:
6.76M
Relative Volume:
0.77
Market Cap:
$83.39B
Revenue:
$19.35B
Net Income/Loss:
$2.78B
P/E Ratio:
54.43
EPS:
1.8696
Net Cash Flow:
$3.82B
1W Performance:
+0.84%
1M Performance:
+2.54%
6M Performance:
-4.04%
1Y Performance:
+16.98%
1-Day Range:
$101.26
$102.70
1-Week Range:
$101.26
$105.65
52-Week Range:
$85.98
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
101.76 | 152.23B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
ABT
Abbott Laboratories
|
130.03 | 227.08B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
360.13 | 138.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.28 | 122.96B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
GEHC
Ge Healthcare Technologies Inc
|
70.63 | 33.32B | 20.25B | 2.29B | 1.40B | 4.8366 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-03-25 | Downgrade | Erste Group | Buy → Hold |
| Sep-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Apr-16-25 | Upgrade | Needham | Hold → Buy |
| Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
Using AI based signals to follow Boston Scientific CorporationMarket Activity Summary & Fast Exit/Entry Strategy Plans - newser.com
Can Boston Scientific Corporation recover in the next quarterNew Guidance & Free Accurate Trade Setup Notifications - newser.com
Does Boston Scientific Corporation stock trade at a discount to peersTrade Signal Summary & Short-Term High Return Strategies - newser.com
Why Boston Scientific Corporation stock is favored by hedge fundsWeekly Trade Report & Free High Accuracy Swing Entry Alerts - newser.com
What earnings revisions data tells us about Boston Scientific Corporation2025 Retail Activity & Risk Controlled Daily Trade Plans - newser.com
Is Boston Scientific's Valuation Justified After 18% Gain and New Product Launches? - Yahoo Finance
What Boston Scientific (BSX)'s Surging Sales and Siemens Partnership Mean for Shareholders - Yahoo! Finance Canada
Boston Scientific gains US distribution duties for Siemens Healthineers’ ICE catheter - Yahoo Finance
Boston Scientific Up 7% in a Month: How Should You Play the Stock? - Finviz
Can Boston Scientific Corporation stock test all time highsQuarterly Portfolio Report & Weekly High Conviction Ideas - newser.com
UBS Boosts Boston Scientific (BSX) Price Target After Strong Q3 Earnings - Insider Monkey
Boston Scientific, Siemens Healthineers ink 4D ICE catheter development deal - MassDevice
Can Boston Scientific Corporation stock deliver consistent EPS growth2025 Big Picture & Scalable Portfolio Growth Methods - newser.com
Boston Scientific enrolls first patient in AFib mapping study using OptiMap, Farapulse - MassDevice
Boston Scientific (BSX) Crossed Above the 200-Day Moving Average: What That Means for Investors - Yahoo Finance
Investors more bullish on Boston Scientific (NYSE:BSX) this week as stock grows 3.7%, despite earnings trending downwards over past five years - Yahoo Finance
CLOSURE-AF study not the end of the line for LAAC devices - BioWorld MedTech
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet - Yahoo Finance
If You Invested $1000 in Boston Scientific a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance
Is Boston Scientific (BSX) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
What's Behind Boston Scientific's Optimism for Urology Growth? - Yahoo Finance
Technical signs of recovery in Boston Scientific CorporationGDP Growth & AI Forecast Swing Trade Picks - newser.com
Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results - Quantisnow
How Recent Developments Are Shaping the Boston Scientific Investment Story - Yahoo Finance
Boston Scientific Corporation (BSX) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Can Boston Scientific Corporation stock sustain revenue momentumTrade Exit Report & Safe Capital Growth Tips - newser.com
Elutia Q3 2025 slides: $88M Boston Scientific deal reshapes strategy amid revenue dip - Investing.com
Insider Sell: Ellen Zane Sells Shares of Boston Scientific Corp (BSX) - GuruFocus
Boston Scientific director Zane sells $1.26 million in stock - Investing.com
Boston Scientific director Zane sells $1.26 million in stock By Investing.com - Investing.com South Africa
[Form 4] BOSTON SCIENTIFIC CORP Insider Trading Activity - Stock Titan
Boston Scientific Corporation (BSX) Stock forecasts - Yahoo! Finance UK
Boston Scientific Corporation (BSX) Stock Forecasts - Yahoo Finance
[144/A] BOSTON SCIENTIFIC CORP SEC Filing - Stock Titan
Boston Scientific (BSX): Evaluating Valuation After Strong Q3 Results and New Product Launches - Yahoo Finance
Top FDA clearances not to be missed - Modern Healthcare News
If EPS Growth Is Important To You, Boston Scientific (NYSE:BSX) Presents An Opportunity - Yahoo Finance
Boston Scientific Corp. (BSX) Stock Price Prediction: 2025, 2026, 2030: Analyst Targets & Forecast - Benzinga
Main Street Research LLC Has $40.96 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Homestead Advisers Corp Has $81.57 Million Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Fullcircle Wealth LLC Takes Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Sustains EP Momentum in Q3: Is More Upside Ahead? - Yahoo Finance
Boston Scientific EVP Joseph Michael Fitzgerald Sells 50,000 Shares - TradingView
Global Pain Management Devices Market Set to Expand Rapidly at a CAGR of ~8% by 2032 Amid Growing Preference for Minimally Invasive Solutions | DelveInsight - GlobeNewswire Inc.
Bank of New York Mellon Corp Has $1.20 Billion Stake in Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific Corporation stock ready for a breakoutJuly 2025 Update & Fast Gain Stock Trading Tips - newser.com
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.43%
3.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):